Endothelin-3 and norepinephrine: Effects on prehepatic portal-hypertensive rats

Pharmacology Reviews and Communications

Volumn 9, Issue 4, 1997, Pages 279-286

  Romay, Salvador ^a   Eizayaga, Francisco X ^a   Castro, Jose Luis ^a   Ricci, Daniel ^a   Lemberg, Abraham ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Endothelin 3; Mean blood pressure; Norepinephrine; Portal blood pressure; Portal hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ENDOTHELIN 3; NORADRENALIN; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SPLEEN;

EID: 0031457525     PISSN: 10288945     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Arranz, C. T., Balaszczuk, A. M., Costa, M. A., Eizayaga, F X., Romay, S., Mongelli, C. and Lemberg, A. (1995) "Systemic baroreflex alterations in prehepatic portal hipertensive conscious rats," Archives of Physiology and Biochemistry, 103, 422-426.
2. Bernardi, M., Gulberg, U., Colantoni, F., Gasbarrini, A. and Gerbes, A. L. (1996) "Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems," Journal of Hepathology, 24, 161-168.
3. Bruning, J. L. and Kintz, B. L. (1977) Computational Handbook of Statistics. 2nd ed. (Scott, Foresman and Co., Glenview, IL.) pp. 113
4. De Nucci, G., Thomas, R , D'Orleans-Juste, P., Antunes, E., Walder, C., Warren, T. D. and Kane, J. R. (1988) "Pressor effects of circulating Endothelin are limited by its removal in the pulmonary circulation and by the release of Prostacyclin and Endothelin Derived Relaxing Factor," Proceedings of National Academy of Sciences, 85, 9797-9800.
5. Flores, J., Legault, L., Morelli, G., Hara, H. and Blendish, L. M (1991) "Increased simpathetic outflow in cirrhosis and ascites: direct evidence for intraneural recordings," Annals of Internal Medicine, 114, 373-380.
6. Fukuda, M , Izumi, Y., Soma, M., Watanabe, Y., Watanabe, M., Hatano, M., Sakuma, I and Yasuda, H. (1990) "L-N-Monomethyl Arginine inhibits the vasodilating effects of low dose of endothelin-3 on rat mesenteric arteries," Biochemical and Biophysical Research Communications, 167, 739-745.
7. Furchgott, R. F. and Vanhourte, P. M. (1989) "Endothelium derived relaxing and contracting factors," FASEB Journal, 3, 2007-2018.
8. Genecin, P. and Groszman, R. J. (1993) Portal hypertension In Diseases of the liver (Lippincott, Philadelphia) pp. 935-973.
9. Hartleb, M., Moreau, R., Cailman, S., Gaudin, C. and Lebrec, D. (1994) "Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis," Gastroenterology, 107, 1085-1093.
10. Haynes, W G. and Webb, D. J. (1993) "The endothelin family of peptides: local hormones with diverse roles in health and disease?" Clinical Sciences, 84, 485-500.
11. Inoue, A , Yanagisawa, M., Kimura, S., Kisuya, Y., Miyauchi, T., Goto, K. and Masaki, T. (1989) "The human endothelins family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes," Proceedings of National Academy of Sciences, 86, 2863-2867.
12. Kiel, J. W., Pitts, V., Benoit, J. N., Granger, D. N. and Shepherd, A. P. (1985) "Reduced vascular sensitivity to norepinephnne in portal-hypertensive rats," American Journal of Physiology, 248, G192-G195.
13. Lemberg, A., Eizayaga, F., Vatta, M., Dominguez, A., Romay, S., Bianciotti, L., Sansó, G. and Fernandez, B. (1993) "Prehephatic portal hypertension in rats modifies norepinephrine metabolism in hypothalamus medulla oblongata and portal vein," Digestive Diseases and Sciences, 38, 1259-1262.
14. Liao, J. F., Yu, P. C., Lin, H. C., Lee, F. Y., Kuo, S. and Ynag, M. C. M. (1994) "Study on the vascular reactivity and aladrenoreceptors of portal hypertensive rats," British Journal of Pharmacology, 111, 439-444.
15. Pizcueta, M P., Casamitjana, R., Bosch, J. and Rodés, J. (1990) "Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism," American Journal of Physiology, 258, G191-G195.
16. Richardson, P. D. I. and Withrington, P. G. (1976) "The inhibition by glucagon of the vasoconstrictor actions of noradrenaline, angiotensine and vasopressin on the hepatic arterial vascular bed of the dog," British Journal of Pharmacology, 57, 93-102.
17. Richardson, P. D. I. and Withrington, P. G. (1977) "The role of b-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, nora- drenaline and adrenaline," British Journal of Pharmacology, 60, 239-249.
18. Sieber, C. C. and Groszmann, R. J. (1992) "Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats," Gastroenterology, 103, 235-239.
19. Sitzmann, J. V., Berkley, G. B., Mitchell, M. C. and Campbell, K. (1989) "Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension," Annah of Surgery, 209, 322-327.
20. Vallance, P. and Moncada, S. (1991) "Hyperdinamic circulation in cirrhosis: a role for nitric oxide?" Lancet, 337, 776-778.
21. Vane, J. R., Änggard, E. E. and Botting, R. M. (1990) "Regulatory functions of the vascular endothelium," New England Journal of Medicine, 323, 27-36.
22. Vorobioff, J., Bredfelt, J. E. and Groszmann, R. J. (1983) "Hyperdinamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension," American Journal of Phisiology, 244, G52-G57.
23. Vorobioff, J., Bredfelt, J. E. and Groszmann, R. J. (1984) "Increased blood flow through the portal system in cirrhotic rats," Gastroenterology, 87, 1120-1126.
24. Warner, T. D., Mitchell, J. A., De Nucci, G. and Vane, J. R. (1989) "Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit," Journal of Cardiovascular Pharmacology, 13, 85-88.
25. Yamashita, J., Yukimura, T., Miura, K., Okurnura, M. and Yamaoto, K. (1991) "Effects of endothelin-3 on renal functions," Journal of Pharmacology and Experimental Therapeutics, 259, 1256-1260.
26. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. and Masaki, T. (1988) "A novel potent vasoconstrictor peptide produced by vascular endothelial cells," Nature, 332, 411-415.
27. Yu, P. Ch., Kuo, J. S., Lin, H. Ch. and Yang, M. C. M (1992) "Effects of endothelin in portal hypertensive rats," Clinical Sciences, 83, 165-170.